[1] 李广栋.慢性心力衰竭患者血清CA125及BNP水平与心功能的相关性分析[J].中国医师杂志,2016,18(s1):170-172. [2] 喻盛杰,陈威.慢性心力衰竭患者血清CA125及BNP水平与心功能的相关性[J].山东医药,2017,57(33):49-50. [3] 陈春林,何秀媚.冠状动脉粥样硬化性心脏病患者血清胱抑素C、CA125和骨保护素检测的临床意义[J].岭南心血管病杂志,2015,21(6):752-754. [4] 孙硕,肖创清,石坚.冠心病患者血清胱抑素C、CA125和骨保护素检测的临床意义[J].医学临床研究,2014,31(7):1335-1340. [5] Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.[J]. J Am Coll Cardiol, 2007, 49(16):1733-1739. [6] 刘哲,王晶.抗心力衰竭治疗对充血性心力衰竭病人BNP及CA125的影响分析[J].中西医结合心脑血管病杂志,2016,14(18):2160-2162. |